Author(s): Li-Saw-Hee FL, Blann AD, Lip GY
Objectives: First, we sought to determine whether there is diurnal variation in hemostatic factors related to thrombogenesis and hypercoagulability among patients with chronic atrial fibrillation (AF). Second, we sought to determine whether levels of soluble thrombomodulin (sTM), a marker of endothelial function, or soluble P-selectin (sP-sel), an index of platelet activation, are altered in patients with AF as compared with subjects in sinus rhythm.
Background: Atrial fibrillation is associated with an increased risk of stroke and thromboembolism and is known to confer a hypercoagulable state, with abnormalities of thrombosis, platelet activation and endothelial cell function. Many cardiovascular events, such as acute myocardial infarction, have thrombosis as an underlying process, and they undergo diurnal variation.
Methods: Fifty-two patients (45 men, mean [+/- SD] age 66 +/- 6 years) with chronic AF, none of whom received antithrombotic therapy, were studied. Baseline levels of fibrinogen, sP-sel, sTM and von Willebrand factor (vWF) were compared to those levels in matched healthy control subjects in sinus rhythm. In a subgroup of 20 patients, five venous blood samples were collected through an indwelling cannula at 6-h intervals from 12 PM to 12 PM the following day and were analyzed for the same markers.
Results: Patients with chronic AF had higher plasma sP-sel, sTM, vWF and fibrinogen levels as compared with control subjects in sinus rhythm. Significant correlations were found between fibrinogen and sP-sel in patients with AF (r = 0.567 [Spearman], p < 0.001) and in control subjects (r = 0.334, p = 0.016). There was no significant diurnal variation in plasma levels of sP-sel, sTM, vWF or fibrinogen over the 24-h study period (repeated measures analysis of variance, p = NS).
Conclusions: There is no circadian or diurnal variation in the hypercoagulable state seen in AF, as assessed by plasma fibrinogen and markers of platelet (sP-sel) and endothelial function (vWF and sTM). The persistent hypercoagulable state, together with the loss of diurnal variation in various hemostatic markers, in chronic AF may contribute to the high risk of stroke and thromboembolic complications in these patients.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/10841245
Author(s): Best JD, Maywood ES, Smith KL, Hastings MH
Author(s): Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M
Author(s): Bargiello TA, Jackson FR, Young MW
Author(s): Shearman LP, Sriram S, Weaver DR, Maywood ES, Chaves I, et al.
Author(s): Panda S, Antoch MP, Miller BH, Su AI, Schook AB, et al.
Author(s): Muller JE, Tofler GH, Stone PH
Author(s): Tsementzis SA, Gill JS, Hitchcock ER, Gill SK, Beevers DG
Author(s): Lavery CE, Mittleman MA, Cohen MC, Muller JE, Verrier RL
Author(s): Manfredini R, Boari B, Smolensky MH, Salmi R, la Cecilia O, et al.
Author(s): Westgate EJ, Cheng Y, Reilly DF, Price TS, Walisser JA, et al.
Author(s): Anea CB, Zhang M, Stepp DW, Simkins GB, Reed G, et al.
Author(s): Rudic RD, Fulton DJ
Author(s): Marshall J
Author(s): Elliott WJ
Author(s): Pardiwalla FK, Yeolekar ME, Bakshi SK
Author(s): Turin TC, Kita Y, Rumana N, Nakamura Y, Takashima N, et al.
Author(s): Casetta I, Granieri E, Fallica E, la Cecilia O, Paolino E, et al.
Author(s): Argentino C, Toni D, Rasura M, Violi F, Sacchetti ML, et al.
Author(s): Marsh EE 3rd, Biller J, Adams HP Jr, Marler JR, Hulbert JR, et al.
Author(s): Chaturvedi S, Adams HP Jr, Woolson RF
Author(s): Marler JR, Price TR, Clark GL, Muller JE, Robertson T, et al.
Author(s): Inagawa T
Author(s): Nagakane Y, Miyashita K, Nagatsuka K, Yamawaki T, Naritomi H
Author(s): Guan JW, Chen MJ, Li H, Liu YY, You C, et al.
Author(s): Guan J, Ding Y, Liu Y, Li Y, Liu Y, et al.
Author(s): Feigin VL, Anderson CS, Rodgers A, Bennett DA
Author(s): Miranpuri AS, AktÃ¼re E, Baggott CD, Miranpuri A, UluÃ§ K, et al.
Author(s): Temes RE, Bleck T, Dugar S, Ouyang B, Mohammad Y, et al.
Author(s): Kelly-Hayes M, Wolf PA, Kase CS, Brand FN, McGuirk JM, et al.
Author(s): Nyquist PA, Brown RD Jr, Wiebers DO, Crowson CS, O'Fallon WM
Author(s): Inagawa T, Takechi A, Yahara K, Saito J, Moritake K, et al.
Author(s): Passero S, Reale F, Ciacci G, Zei E
Author(s): Abe T, Ohde S, Ishimatsu S, Ogata H, Hasegawa T, et al.
Author(s): Inagawa T
Author(s): Brezinski DA, Tofler GH, Muller JE, Pohjola-Sintonen S, Willich SN, et al.
Author(s): Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, et al.
Author(s): Panza JA, Epstein SE, Quyyumi AA
Author(s): Jain S, Namboodri KK, Kumari S, Prabhakar S
Author(s): Castilla-Guerra L, Espino-Montoro A, Fernandez-Moreno MC, Lopez-Chozas JM
Author(s): Naess H, Idicula T, Brogger J, Waje-Andreassen U, Thomassen L
Author(s): Spengos K, Vemmos K, Tsivgoulis G, Manios E, Zakopoulos N, et al.
Author(s): Riccio PM, Klein FR, PaganiCassarÃ¡ F, MuÃ±oz Giacomelli F, GonzÃ¡lez Toledo ME, et al.
Author(s): Takahashi JS, Hong HK, Ko CH, McDearmon EL
Author(s): Yagita K, Tamanini F, Yasuda M, Hoeijmakers JH, van der Horst GT, et al.
Author(s): Meng QJ, Logunova L, Maywood ES, Gallego M, Lebiecki J, et al.
Author(s): Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, et al.